New Leukemia Txs, Fewer Blood Clots With GLP-1 Rxs
SAN DIEGO — Groundbreaking studies into leukemia treatments and the effects of glucagon-like peptide 1 (GLP-1) inhibitors on venous thromboembolism ...
SAN DIEGO — Groundbreaking studies into leukemia treatments and the effects of glucagon-like peptide 1 (GLP-1) inhibitors on venous thromboembolism ...
TOPLINE:Sotagliflozin, a dual sodium-glucose cotransporter 1 and 2 inhibitor, rapidly improves hemoglobin levels in patients with type 2 diabetes (T2D) ...
TOPLINE:A link between hepatic fat and intrapancreatic fat deposition (IPFD) in young and middle-aged adults without obesity and with low ...
TOPLINE:Individuals with normal body mass index (BMI) measurements may still face an increased risk for colorectal cancer (CRC) if they ...
The emergence of vorasidenib, the first targeted therapy for certain gliomas with IDH mutations, has ignited a wave of excitement ...
Older adults who are sensitive to the distress of others are more likely to feel anxious or depressed themselves because ...
Antimicrobial resistance (AMR) is globally recognized as one of the greatest health threats of the 21st century, responsible for 1.27 ...
CHICAGO — A randomized placebo-controlled trial testing a direct oral anticoagulant for the prevention of cognitive decline in patients with ...
OuraSmart rings have built-in sensors that monitor the wearer's heart rate and other health issuesWearable tech – currently dominated by ...
HOUSTON -- Kimberly Rubit had one priority in mind as Hurricane Beryl ripped through Houston this summer: her severely disabled ...
Kanaparthy is a practicing internal medicine physician specializing in clinical informatics. President-elect Donald Trump's pick for secretary of education, Linda ...
Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and middle-age adults, ...
PA MediaA public inquiry described the scale of the scandal as "horrifying"Some victims of the infected blood scandal have been ...
© 2022 NewsHealth.
© 2022 NewsHealth.